Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133382) titled 'Severe bilateral corneal epitheliopathy after the first treatment cycle of trastuzumab botidotin: a case report' on Sept. 24.
Study Type: Observational study
Study Design:
Case study
Primary Sponsor: The Fifth Affiliated Hospital, Sun Yat-Sen University
Condition:
breast cancer
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-24
Target Sample Size: Case group:1;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=345258
Published by HT Digital Content Services with permission from Health Daily Digest....